| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99199 |
Unlisted special service, procedure or report |
354,325 |
293,639 |
$1.77M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,129 |
2,365 |
$333K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,670 |
3,559 |
$329K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
9,556 |
7,789 |
$120K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,450 |
2,018 |
$57K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
489 |
344 |
$29K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
247 |
220 |
$21K |
| 90834 |
Psychotherapy, 45 minutes with patient |
327 |
184 |
$20K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
749 |
529 |
$20K |
| 99215 |
Prolong outpt/office vis |
108 |
68 |
$19K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
158 |
143 |
$14K |
| 90686 |
|
4,594 |
3,862 |
$11K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
110 |
101 |
$9K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
977 |
801 |
$9K |
| 96127 |
|
2,215 |
1,594 |
$8K |
| 90651 |
|
123 |
102 |
$4K |
| 90715 |
|
374 |
308 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
541 |
406 |
$4K |
| 81003 |
|
1,382 |
896 |
$3K |
| 90734 |
|
238 |
194 |
$3K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
24 |
15 |
$3K |
| 96161 |
|
740 |
594 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
152 |
128 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,086 |
827 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
16 |
12 |
$2K |
| 87210 |
|
438 |
307 |
$2K |
| 90480 |
|
32 |
27 |
$1K |
| 96160 |
|
416 |
268 |
$1K |
| 86580 |
|
176 |
142 |
$886.97 |
| 90620 |
|
24 |
19 |
$716.00 |
| 90656 |
|
196 |
179 |
$538.32 |
| 85027 |
|
79 |
54 |
$486.19 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
15 |
12 |
$478.24 |
| 92551 |
|
508 |
445 |
$339.55 |
| 90619 |
|
174 |
133 |
$230.00 |
| 99401 |
|
46 |
31 |
$224.76 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
42 |
14 |
$181.40 |
| 90707 |
|
24 |
14 |
$180.00 |
| 90716 |
|
51 |
40 |
$160.00 |
| 90633 |
|
15 |
14 |
$24.00 |
| 90698 |
|
25 |
25 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
188 |
168 |
$0.00 |
| 86592 |
|
12 |
12 |
$0.00 |
| 36416 |
|
130 |
106 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
32 |
31 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
12 |
12 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
188 |
168 |
$0.00 |
| 83655 |
|
14 |
12 |
$0.00 |
| 80061 |
Lipid panel |
17 |
16 |
$0.00 |
| 99177 |
|
184 |
170 |
$0.00 |
| 90670 |
|
114 |
108 |
$0.00 |
| 81025 |
|
13 |
13 |
$0.00 |
| 99173 |
|
12 |
12 |
$0.00 |